- Home
- RPRX vs HLI Comparison
RPRX vs HLI Comparison
Compare RPRX & HLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RPRX
- HLI
- Stock Information
- Founded
- RPRX 1996
- HLI 1972
- Country
- RPRX United States
- HLI United States
- Employees
- RPRX 89
- HLI N/A
- Industry
- RPRX Biotechnology: Pharmaceutical Preparations
- HLI Investment Managers
- Sector
- RPRX Health Care
- HLI Finance
- Exchange
- RPRX Nasdaq
- HLI Nasdaq
- Market Cap
- RPRX 13.6B
- HLI 12.2B
- IPO Year
- RPRX 2020
- HLI 2015
- Fundamental
- Price
- RPRX $30.93
- HLI $187.74
- Analyst Decision
- RPRX Strong Buy
- HLI Hold
- Analyst Count
- RPRX 6
- HLI 6
- Target Price
- RPRX $41.67
- HLI $173.40
- AVG Volume (30 Days)
- RPRX 3.4M
- HLI 400.0K
- Earning Date
- RPRX 02-13-2025
- HLI 01-28-2025
- Dividend Yield
- RPRX 2.74%
- HLI 1.22%
- EPS Growth
- RPRX 518.56
- HLI 30.39
- EPS
- RPRX 2.55
- HLI 4.89
- Revenue
- RPRX $2,266,003,000.00
- HLI $2,119,860,999.00
- Revenue This Year
- RPRX $14.54
- HLI $21.20
- Revenue Next Year
- RPRX $10.94
- HLI $15.73
- P/E Ratio
- RPRX $11.99
- HLI $38.16
- Revenue Growth
- RPRX N/A
- HLI 18.82
- 52 Week Low
- RPRX $24.05
- HLI $119.28
- 52 Week High
- RPRX $31.66
- HLI $192.10
- Technical
- Relative Strength Index (RSI)
- RPRX 75.82
- HLI 64.31
- Support Level
- RPRX $29.73
- HLI $164.05
- Resistance Level
- RPRX $31.09
- HLI $186.89
- Average True Range (ATR)
- RPRX 0.73
- HLI 3.02
- MACD
- RPRX 0.28
- HLI 2.05
- Stochastic Oscillator
- RPRX 93.94
- HLI 97.15
About RPRX Royalty Pharma plc
Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.
About HLI Houlihan Lokey Inc.
Houlihan Lokey Inc is an investment bank with expertise in mergers and acquisitions, capital markets, financial restructuring, valuation, and strategic consulting. The firm serves corporations, institutions, and governments worldwide with offices in the United States, Europe, and the Asia-Pacific region. The company operates in three segments. In the Corporate Finance business segment, it provides M&A and capital markets advisory services. Through the Financial Restructuring business segment, the company advises on some of the complex restructurings around the world. Financial and Valuation Advisory Services business segment provides valuation and financial opinion, and financial and strategic consulting practices in the United States.